{
    "id": "58508563",
    "text": "Levonorgestrel cyclopropylcarboxylate (developmental code name HRP-003), or levonorgestrel 17\u03b2-cyclopropylcarboxylate, is a progestin and a progestogen ester which was studied for potential use as an injectable hormonal contraceptive but was never marketed.Benagiano, G., & Merialdi, M. (2011). Carl Djerassi and the World Health Organisation special programme of research in human reproduction. Journal f\u00fcr Reproduktionsmedizin und Endokrinologie- Journal of Reproductive Medicine and Endocrinology, 8(1), 10-13. http://www.kup.at/kup/pdf/10163.pdf It was developed by the World Health Organization's Special Programme on Human Reproduction in the 1980s. Analogues of levonorgestrel cyclopropylcarboxylate include levonorgestrel cyclobutylcarboxylate (HRP-001) and levonorgestrel butanoate (HRP-002). ==See also== * List of progestogen esters \u00a7 Esters of 19-nortestosterone derivatives * Progestogen-only injectable contraceptive ==References== Category:Abandoned drugs Category:Alkyne derivatives Category:Androgens and anabolic steroids Category:Carboxylic acids Category:Estranes Category:Enones Category:Prodrugs Category:Progestogens Category:Progestogen esters Category:World Health Organization ",
    "title": "Levonorgestrel cyclopropylcarboxylate"
}